白血病·淋巴瘤
白血病·淋巴瘤
백혈병·림파류
JOURNAL OF LEUKEMIA & LYMPHOMA
2010年
9期
552-554
,共3页
陈秀花%王宏伟%齐喜玲%覃艳红%李秋杏%乔娜%张丽%任方刚
陳秀花%王宏偉%齊喜玲%覃豔紅%李鞦杏%喬娜%張麗%任方剛
진수화%왕굉위%제희령%담염홍%리추행%교나%장려%임방강
骨髓增殖性疾病%JAK2 V617F突变%MP Lexon10突变
骨髓增殖性疾病%JAK2 V617F突變%MP Lexon10突變
골수증식성질병%JAK2 V617F돌변%MP Lexon10돌변
Myeloproliferative disorders%JAK2 V617F-negtive%MPL exon 10 mutations
目的 探讨MPLexon10突变在JAK2V617F阴性骨髓增殖性肿瘤(MPN)中的发生情况.方法 对235例MPN患者进行JAK2 V617F检测,对检出的103例阴性患者应用等位基因特异性聚合酶链反应(ASP-PCR)联合测序检测MPL exon10已知基因突变MPLW515K/L;应用DNA单链构象多态性聚合酶链反应(SSCP-PCR)联合测序检测MPL exon10未知突变.结果 103例JAK2 V617F阴性MPN患者中MPLW515K/L检出1例MPLW515K(TGG→AAG),为原发性骨髓纤维化(PMF)患者;MPLexon10未知突变检测发现1例原发性血小板增多症(ET)患者存在新的突变类型,即MPL核苷酸1491-1492位之间插入12个碱基(CTGGTGATCGCT),且为纯合突变.结论 JAK2 V617F阴性MPN患者在MPL基因exon10区域内除已知W515K/L突变外尚存在新的突变位点,但突变率较低.
目的 探討MPLexon10突變在JAK2V617F陰性骨髓增殖性腫瘤(MPN)中的髮生情況.方法 對235例MPN患者進行JAK2 V617F檢測,對檢齣的103例陰性患者應用等位基因特異性聚閤酶鏈反應(ASP-PCR)聯閤測序檢測MPL exon10已知基因突變MPLW515K/L;應用DNA單鏈構象多態性聚閤酶鏈反應(SSCP-PCR)聯閤測序檢測MPL exon10未知突變.結果 103例JAK2 V617F陰性MPN患者中MPLW515K/L檢齣1例MPLW515K(TGG→AAG),為原髮性骨髓纖維化(PMF)患者;MPLexon10未知突變檢測髮現1例原髮性血小闆增多癥(ET)患者存在新的突變類型,即MPL覈苷痠1491-1492位之間插入12箇堿基(CTGGTGATCGCT),且為純閤突變.結論 JAK2 V617F陰性MPN患者在MPL基因exon10區域內除已知W515K/L突變外尚存在新的突變位點,但突變率較低.
목적 탐토MPLexon10돌변재JAK2V617F음성골수증식성종류(MPN)중적발생정황.방법 대235례MPN환자진행JAK2 V617F검측,대검출적103례음성환자응용등위기인특이성취합매련반응(ASP-PCR)연합측서검측MPL exon10이지기인돌변MPLW515K/L;응용DNA단련구상다태성취합매련반응(SSCP-PCR)연합측서검측MPL exon10미지돌변.결과 103례JAK2 V617F음성MPN환자중MPLW515K/L검출1례MPLW515K(TGG→AAG),위원발성골수섬유화(PMF)환자;MPLexon10미지돌변검측발현1례원발성혈소판증다증(ET)환자존재신적돌변류형,즉MPL핵감산1491-1492위지간삽입12개감기(CTGGTGATCGCT),차위순합돌변.결론 JAK2 V617F음성MPN환자재MPL기인exon10구역내제이지W515K/L돌변외상존재신적돌변위점,단돌변솔교저.
Objective To explore the frequencies of MPL exon 10 mutations in JAK2 V617F-negative myeloproliferative neoplasms patients. Methods MPLW515K/L was processed through allele-specific PGR combined with direct sequence analysis. The mutations of others MPL exon 10 were detected by single strand conformation polymorphism PGR (PCR-SSCP) combined with direct sequencing. Results Of the 103 patients with JAK2 V617F-negtive myeloproliferative neoplasms patients, 1 carried MPLW515K mutation (TGG→AAG)in PMF; 1 was found to have new mutation (CTGGTGATCGCT insert) in ET and have homozygous mutation. Conclusion JAK2 V617F-negtive myeloproliferative neoplasms patients carried additional mutations in addition to W515K/L mutations in MPL exon 10, but its frequency of mutation is low.